InvestSMART

Oneview Healthcare Plc (ASX:ONE)

ALERT: Price-sensitive ASX Announcement for ONE
Current share price for ONE : $0.160 -0.08 (-33.33%)+
Announcement
Release
13 Aug 2025 8:24AM
Price at Release
$0.240
Full Release
download
Summary
The Half Yearly Report and Accounts for Oneview Healthcare Plc for the six months ended 30 June 2023 provide an overview of the company's operational and financial performance. The report highlights increased demand for the company's Cloud Enterprise solution, expanded client base, and growing recurring revenues. It notes a significant contract win with a large US health network, the successful go-live of their CXP Cloud Enterprise platform, and entry into new geographies including the Middle East. Financially, the company reported growth in recurring revenue and a reduction in EBITDA loss, reflecting operational efficiencies and improved cost management. Oneview also discusses continued investment in product development, a strengthened financial position following a successful capital raise, and a positive outlook driven by an expanding sales pipeline and adoption of its healthcare solutions.
Key Points
  • Reported increased demand for Oneview's Cloud Enterprise solution and growing client base.
  • Signed a significant contract with a major US health system for 85,000 beds.
  • Delivered successful go-live of CXP Cloud Enterprise platform in key markets.
  • Entered new geographies, notably the Middle East.
  • Recurring revenue grew and EBITDA loss narrowed due to operational efficiencies.
  • Continued investment in product innovation and development.
  • Completed successful capital raise to support growth and strengthen financial position.
  • Maintains a strong sales pipeline and expects continued growth in adoption of its solutions.
  • Focus remains on recurring revenue growth, operational excellence, and expanding global footprint.
  • Directors confirm the company has adequate resources for continued operations and growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.